These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 15057897)
21. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319 [TBL] [Abstract][Full Text] [Related]
23. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Bajaj JS; Hafeezullah M; Franco J; Varma RR; Hoffmann RG; Knox JF; Hischke D; Hammeke TA; Pinkerton SD; Saeian K Gastroenterology; 2008 Nov; 135(5):1591-1600.e1. PubMed ID: 18723018 [TBL] [Abstract][Full Text] [Related]
26. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331 [TBL] [Abstract][Full Text] [Related]
27. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)]. Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303 [TBL] [Abstract][Full Text] [Related]
29. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy? Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235 [TBL] [Abstract][Full Text] [Related]
30. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Stewart CA; Malinchoc M; Kim WR; Kamath PS Liver Transpl; 2007 Oct; 13(10):1366-71. PubMed ID: 17520742 [TBL] [Abstract][Full Text] [Related]
31. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Amorós A; Aparicio JR; Garmendia M; Casellas JA; Martínez J; Jover R Gastrointest Endosc; 2009 Aug; 70(2):262-8. PubMed ID: 19394004 [TBL] [Abstract][Full Text] [Related]
32. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Sharma P; Sharma BC; Puri V; Sarin SK Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909 [TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Mittal VV; Sharma BC; Sharma P; Sarin SK Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis. Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213 [TBL] [Abstract][Full Text] [Related]
35. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Jover R; Compañy L; Gutiérrez A; Zapater P; Pérez-Serra J; Girona E; Aparicio JR; Pérez-Mateo M Am J Gastroenterol; 2003 Jul; 98(7):1599-604. PubMed ID: 12873585 [TBL] [Abstract][Full Text] [Related]
36. Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. Marić D; Klasnja B; Filipović D; Brkić S; Ruzić M; Bugarski V Acta Clin Croat; 2011 Sep; 50(3):375-80. PubMed ID: 22384773 [TBL] [Abstract][Full Text] [Related]
37. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Sugimoto R; Iwasa M; Maeda M; Urawa N; Tanaka H; Fujita N; Kobayashi Y; Takeda K; Kaito M; Takei Y Am J Gastroenterol; 2008 Jun; 103(6):1413-20. PubMed ID: 18510613 [TBL] [Abstract][Full Text] [Related]
38. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. Gupta D; Ingle M; Shah K; Phadke A; Sawant P J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627 [TBL] [Abstract][Full Text] [Related]
39. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Oppong KN; Al-Mardini H; Thick M; Record CO Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307 [TBL] [Abstract][Full Text] [Related]
40. Minimal hepatic encephalopathy. Stewart CA; Smith GE Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]